Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
  1. 4 Planned sale Chief Regulatory Officer sold 10,000 shares at $50.08 ($500,767)
  2. 4 Open-market buy Director bought 5,882 shares at $42.50 ($249,985)
  3. 4 Planned sale Chief Regulatory Officer sold 10,000 shares at $45.31 ($453,053)
  4. 4 Planned sale Chief Regulatory Officer sold 10,000 shares at $40.00 ($400,000)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Chief Legal Officer sold 3,864 shares at $27.82 ($107,498)
  8. 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 15,000 shares at $29.06 ($435,875)
  9. 4 Open-market buy Director bought 250,000 shares at an average $21.11 ($5,277,311)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale PRESIDENT AND CEO sold 19,688 shares at an average $27.78 ($546,914)
  19. 4 Grant or award SVP, FINANCE, CHIEF ACCT OFFCR acquired 10,740 shares (grant or award)
  20. 4 Grant or award Chief Development Officer acquired 22,500 shares (grant or award)

Page 3 of 12 · 230 filings